Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

December 31, 2026

Conditions

Extracorporeal Membrane Oxygenation Complication

Interventions

DRUG

nafamostat mesilate

Use nafamostat mesilate as an anticoagulant

DRUG

unfractionated heparin group

Use unfractionated heparin as an anticoagulant

Trial Locations (1)

RECRUITING

Beijing Anzhen Hospital, Beijing

All Listed Sponsors

lead

Xiaotong Hou

OTHER